CITIC Securities released a research report stating that as the National Medical Insurance Administration strengthens its review of medical insurance fund usage at pharmacies, ALI HEALTH's (00241) pharmaceutical e-commerce business is expected to significantly benefit from the online migration trend in pharmaceutical retail. Meanwhile, during this process, the company's traceability code business can provide core technical support. The company is steadily advancing testing work for its "Hydrogen Ion" medical Q&A platform, with AI applications in pharmaceutical search and recommendation scenarios improving service experience and enhancing operational efficiency. The firm maintains its "BUY" rating.